IC

Ikarian Capital Portfolio holdings

AUM $302M
1-Year Est. Return 65.21%
This Quarter Est. Return
1 Year Est. Return
+65.21%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$349M
AUM Growth
-$87.3M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
198
New
Increased
Reduced
Closed

Top Buys

1
+$17.1M
2
+$8.3M
3
+$6.55M
4
CLDX icon
Celldex Therapeutics
CLDX
+$5.75M
5
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$5.39M

Top Sells

1
+$11.5M
2
+$7.89M
3
+$6.85M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$6.66M
5
XENE icon
Xenon Pharmaceuticals
XENE
+$6.2M

Sector Composition

1 Healthcare 97.45%
2 Consumer Staples 0.57%
3 Technology 0.57%
4 Financials 0.21%
5 Real Estate 0.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
101
$451K 0.07%
9,959
102
$442K 0.07%
118,063
103
$433K 0.06%
208,306
104
$431K 0.06%
3,392
105
$416K 0.06%
60,579
106
$402K 0.06%
50,000
-694,616
107
$398K 0.06%
64
108
$397K 0.06%
478,561
109
$395K 0.06%
73,882
110
$388K 0.06%
122,842
111
$385K 0.06%
28
112
$372K 0.06%
+533
113
$370K 0.06%
+73,530
114
$332K 0.05%
5,258
115
$317K 0.05%
+20,000
116
$310K 0.05%
4,523
117
$307K 0.05%
853,680
-50,000
118
$262K 0.04%
21,427
-15,000
119
$262K 0.04%
35,048
-527,198
120
$228K 0.03%
196,821
121
$222K 0.03%
+70,000
122
$204K 0.03%
1,195
-266
123
$200K 0.03%
+2,161
124
$197K 0.03%
14,748
125
$195K 0.03%
14,813
3 4
5
6 7